Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?

Clinical pharmacology has, unquestionably, become more politicised than any other biomedical discipline because of the global importance and impact--and the controversies--that the subject arouses.

Saved in:
Bibliographic Details
Published in:European journal of clinical pharmacology 2013-05, Vol.69 (Suppl 1), p.11-15
Main Author: Rawlins, Michael D
Format: Article
Language:English
Subjects:
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cost-Benefit Analysis
Drug Industry
Humans
Medical sciences
Pharmaceutical Preparations
Pharmacology
Pharmacology, Clinical
Pharmacology. Drug treatments
Pharmacology/Toxicology
Politics
Risk Assessment
Social Values
Special Article
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c402t-582325c49b07068d395a4e44173aaab5d09662fd8fc0e71b9e47c100dff126c03
cites cdi_FETCH-LOGICAL-c402t-582325c49b07068d395a4e44173aaab5d09662fd8fc0e71b9e47c100dff126c03
container_end_page 15
container_issue Suppl 1
container_start_page 11
container_title European journal of clinical pharmacology
container_volume 69
creator Rawlins, Michael D
description Clinical pharmacology has, unquestionably, become more politicised than any other biomedical discipline because of the global importance and impact--and the controversies--that the subject arouses.
doi_str_mv 10.1007/s00228-013-1473-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1350149737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3046760081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-582325c49b07068d395a4e44173aaab5d09662fd8fc0e71b9e47c100dff126c03</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhi1UBFvgB3BBkSqkXgIz_oiTXhBCFJCQ4ABny3EcauSNg50c9t_j1S60qsRpDvPMzDsPIccIZwggzxMApXUJyErkkpWwQxbIGS0ROH4jCwCGZdVI2CffU3oFQNEA2yP7lFUcsGYLcvf4R8elNmEM3k3OpF9FtL23ZnJhSEUYCl2kuU2jNU77aVWEvjDeDc5oX4zbWR9eVheHZLfXPtmjbT0gz7-vn65uy_uHm7ury_vScKBTKWrKqDC8aUFCVXesEZpbzlEyrXUrOmiqivZd3RuwEtvGcmnyt13fI60MsAPyc7N3jOFttmlSS5eM9V4PNsxJIROAvJFMZvTHf-hrmOOQ0ynklDMhJKwp3FAmhpTy92qMbqnjSiGotWe18ayyZ7X2rNYhTrab53Zpu8-JD7EZON0COmVVfdSDcekvJ4VspMTM0Q2Xcmt4sfGfiF9efwdlbZOM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1424355707</pqid></control><display><type>article</type><title>Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?</title><source>Springer Nature</source><creator>Rawlins, Michael D</creator><creatorcontrib>Rawlins, Michael D</creatorcontrib><description>Clinical pharmacology has, unquestionably, become more politicised than any other biomedical discipline because of the global importance and impact--and the controversies--that the subject arouses.</description><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/s00228-013-1473-0</identifier><identifier>PMID: 23640183</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cost-Benefit Analysis ; Drug Industry ; Humans ; Medical sciences ; Pharmaceutical Preparations ; Pharmacology ; Pharmacology, Clinical ; Pharmacology. Drug treatments ; Pharmacology/Toxicology ; Politics ; Risk Assessment ; Social Values ; Special Article</subject><ispartof>European journal of clinical pharmacology, 2013-05, Vol.69 (Suppl 1), p.11-15</ispartof><rights>Springer-Verlag Berlin Heidelberg 2013</rights><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-582325c49b07068d395a4e44173aaab5d09662fd8fc0e71b9e47c100dff126c03</citedby><cites>FETCH-LOGICAL-c402t-582325c49b07068d395a4e44173aaab5d09662fd8fc0e71b9e47c100dff126c03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27579771$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23640183$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rawlins, Michael D</creatorcontrib><title>Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><addtitle>Eur J Clin Pharmacol</addtitle><description>Clinical pharmacology has, unquestionably, become more politicised than any other biomedical discipline because of the global importance and impact--and the controversies--that the subject arouses.</description><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cost-Benefit Analysis</subject><subject>Drug Industry</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmaceutical Preparations</subject><subject>Pharmacology</subject><subject>Pharmacology, Clinical</subject><subject>Pharmacology. Drug treatments</subject><subject>Pharmacology/Toxicology</subject><subject>Politics</subject><subject>Risk Assessment</subject><subject>Social Values</subject><subject>Special Article</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp1kE1P3DAQhi1UBFvgB3BBkSqkXgIz_oiTXhBCFJCQ4ABny3EcauSNg50c9t_j1S60qsRpDvPMzDsPIccIZwggzxMApXUJyErkkpWwQxbIGS0ROH4jCwCGZdVI2CffU3oFQNEA2yP7lFUcsGYLcvf4R8elNmEM3k3OpF9FtL23ZnJhSEUYCl2kuU2jNU77aVWEvjDeDc5oX4zbWR9eVheHZLfXPtmjbT0gz7-vn65uy_uHm7ury_vScKBTKWrKqDC8aUFCVXesEZpbzlEyrXUrOmiqivZd3RuwEtvGcmnyt13fI60MsAPyc7N3jOFttmlSS5eM9V4PNsxJIROAvJFMZvTHf-hrmOOQ0ynklDMhJKwp3FAmhpTy92qMbqnjSiGotWe18ayyZ7X2rNYhTrab53Zpu8-JD7EZON0COmVVfdSDcekvJ4VspMTM0Q2Xcmt4sfGfiF9efwdlbZOM</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Rawlins, Michael D</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20130501</creationdate><title>Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?</title><author>Rawlins, Michael D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-582325c49b07068d395a4e44173aaab5d09662fd8fc0e71b9e47c100dff126c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cost-Benefit Analysis</topic><topic>Drug Industry</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmaceutical Preparations</topic><topic>Pharmacology</topic><topic>Pharmacology, Clinical</topic><topic>Pharmacology. Drug treatments</topic><topic>Pharmacology/Toxicology</topic><topic>Politics</topic><topic>Risk Assessment</topic><topic>Social Values</topic><topic>Special Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rawlins, Michael D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rawlins, Michael D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?</atitle><jtitle>European journal of clinical pharmacology</jtitle><stitle>Eur J Clin Pharmacol</stitle><addtitle>Eur J Clin Pharmacol</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>69</volume><issue>Suppl 1</issue><spage>11</spage><epage>15</epage><pages>11-15</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><abstract>Clinical pharmacology has, unquestionably, become more politicised than any other biomedical discipline because of the global importance and impact--and the controversies--that the subject arouses.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>23640183</pmid><doi>10.1007/s00228-013-1473-0</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6970
ispartof European journal of clinical pharmacology, 2013-05, Vol.69 (Suppl 1), p.11-15
issn 0031-6970
1432-1041
language eng
recordid cdi_proquest_miscellaneous_1350149737
source Springer Nature
subjects Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cost-Benefit Analysis
Drug Industry
Humans
Medical sciences
Pharmaceutical Preparations
Pharmacology
Pharmacology, Clinical
Pharmacology. Drug treatments
Pharmacology/Toxicology
Politics
Risk Assessment
Social Values
Special Article
title Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A15%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacopolitics:%20reflections%20on%20a%20subspecialty%20of%20clinical%20pharmacology?&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=Rawlins,%20Michael%20D&rft.date=2013-05-01&rft.volume=69&rft.issue=Suppl%201&rft.spage=11&rft.epage=15&rft.pages=11-15&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/s00228-013-1473-0&rft_dat=%3Cproquest_cross%3E3046760081%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c402t-582325c49b07068d395a4e44173aaab5d09662fd8fc0e71b9e47c100dff126c03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1424355707&rft_id=info:pmid/23640183&rfr_iscdi=true